百家乐怎么玩-澳门百家乐官网娱乐城网址_网上百家乐是不是真的_全讯网888 (中国)·官方网站

Mapping a biotech future in Hong Kong

Regina Lau

 

Recent biotech achievements in China offer immense opportunities for Hong Kong to enhance her position in biotechnology, one of the most promising industries for coming decades, said Professor Y L Lo, Founding Chairman of the Hong Kong Biotechnology Association, at CityU on 20 January. Professor Lo's lecture, "Biotechnology-the Catalyst of Hong Kong's Future Economic Development?" was the latest in the Distinguished Industrialist Lecture Series, organized by CityU's Faculty of Science and Engineering to foster closer links between the University community and the business sector. "Collaborating with China and participation in i

nternational biotech projects are crucial steps for Hong Kong to establish itself in this mega trend for the 21st century," he told the audience.

Professor Lo, who is also the President (Asia Pacific) of PerkinElmer Life and Sciences (Hong Kong) Limited, a US based biotech company, gave a comprehensive picture of biotech development in the Asia Pacific region, which is set to become the engine for global economic growth. Governments in Taiwan, Korea, Singapore and Japan have shown a clear commitment to expanding the biotech industry, which has also experienced booming investment from the private sector. With her growing contributions to the Human Genome Project, breakthroughs in decoding the hybrid rice genome, and production of recombinant drugs and vaccines, China is capable of becoming a future leader in the Asia biotech industry, he said.

"In Hong Kong, the biotech industry is currently very much trade-based. We are lagging behind our neighbors in terms of technological innovation and R&D investment," said Professor Lo. "But with a strong service base, heightened awareness among our entrepreneurs of the huge potential of the life science industry, and our position as China's bridge to the world, Hong Kong is well situated to find a niche in the booming biotech field."

The process of commercialization and technology transfer in biotechnology creates huge opportunities for various sectors, including the legal and fina

nce sectors. Instead of starting from scratch, Hong Kong should focus on the advanced stages of the process, Professor Lo said. "Immense opportunities in servicing and intellectual property protection at the advanced stage of the process are waiting to be explored." 

 

你可能感興趣

聯絡資料

傳訊及數據研究處

Back to top
网上百家乐官网游戏玩法| 网络百家乐官网破解器| 棋牌百家乐有稳赚的方法吗 | 网上百家乐官网公式| 属猪的人做生意摆放什么聚财| 罗浮宫百家乐的玩法技巧和规则| 百家乐官网分析软件下| 百家乐博彩平| 百家乐官网赌场代理合作| 大发888娱乐场下| 请问下百家乐官网去哪个娱乐城玩最好呢| bet365娱乐在线| 菲彩百家乐官网的玩法技巧和规则 | 百家乐官网最好投注| 百家乐开户优惠多的平台是哪家| 渝中区| 百家乐生活馆拖鞋| 百家乐官网有哪几种| 威尼斯人娱乐城怎么样lm0| 澳门百家乐洗码提成查询| 百家乐官网赌场详解| 德州扑克大小规则| e世博百家乐技巧| 百家乐官网真钱路怎么看| 大发888游戏优惠| 百家乐是怎样的| 评测百家乐官网博彩网站| 大发888 xp缺少 casino| 百家乐赌博机原理| 百家乐官网如何赚钱洗码| 仪陇县| 大发888娱乐城在线客服| 菲律宾百家乐娱乐场| 百家乐官网麻将筹码币| 摩纳哥百家乐官网娱乐城| 大赢家足球比分| 二八杠技术| 百家乐平点| 百家乐断缆赢钱| 诸子百家乐官网的玩法技巧和规则 | 怎么赌百家乐能赢|